scholarly journals Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization

2015 ◽  
Vol 3 ◽  
Author(s):  
Andreas Vilhelmsson
Author(s):  
Cecilia T. Hardacker ◽  
Anna Baccellieri ◽  
Elizabeth R. Mueller ◽  
Linda Brubaker ◽  
Georgia Hutchins ◽  
...  

We appreciate your comments and concerns about our manuscript in IJERPH on Bladder Health Experiences, Perceptions and Knowledge of Sexual and Gender Minorities [...]


2015 ◽  
Vol 38 (2) ◽  
pp. 237-242 ◽  
Author(s):  
M. Willmott ◽  
J. Womack ◽  
W. Hollingworth ◽  
R. Campbell

Author(s):  
Joshua S. Jue ◽  
Mahmoud Alameddine

Our knowledge of voiding is derived from studies comprised of cisgender males and females, with relatively little known about the impact of sexual and gender minority status on voiding perceptions, symptoms, and function [...]


2018 ◽  
Vol 16 (1) ◽  
pp. 75-106
Author(s):  
Željko Dugac

Da bi se stekla kontrola i prevlast na određenom području, medicina je često služila kao alat za promicanje različitih interesa. Tragom aktivnosti Zdravstvene organizacije Lige naroda i Rockefellerove fondacije na području Kine 1930-ih, ovaj rad analizira međusobno povezivanje međunarodnih i mjesnih čimbenika u preobrazbi tradicionalne kineske sredine u skladu s novim i trendovskim projektima javnog zdravstva. Te su aktivnosti provedene ne samo radi poboljšanja uvjeta javnog zdravstva u zemlji već i zbog uvođenja kineskoga javnog zdravstva u proces internacionalizacije i standardizacije prema zapadno orijentiranom tipu medicine i medicinskog obrazovanja. Politički utjecaji, gospodarski interesi i kulturno okruženje, kao i vojne akcije u ovom vrlo burnom razdoblju kineske povijesti nužno su djelovali na započete procese. Djelatnosti javnog zdravstva provodila je skupina međunarodnih stručnjaka. Među njima glavnu su ulogu imala dva hrvatska liječnika: Andrija Štampar (poslije jedan od osnivača Svjetske zdravstvene organizacije) i Berislav Borčić (ravnatelj Škole javnog zdravstva u Zagrebu). Na temelju korespondencije između ta dva liječnika, kao i putopisnog dnevnika Andrije Štampara, ovaj esej prikazuje neke manje poznate pojedinosti o stanju u Kini i međusobnom isprepletanju politike i medicine.


2021 ◽  
Author(s):  
Everdina W. Tiemersma ◽  
Ali Ibrahim ◽  
Asnakech Alemu ◽  
Yohanna Kambai Avong ◽  
Alemayehu Duga ◽  
...  

Abstract Background: New medicines have become available for the treatment of drug-resistant tuberculosis (DR-TB) and are introduced in sub-Saharan Africa (SSA) by the national TB programs (NTPs) through special access schemes. Pharmacovigilance is typically the task of national medicines regulatory agencies (NMRAs), but the active drug safety monitoring and management (aDSM) recommended for the new TB medicines and regimens was introduced through the NTPs.We assessed the strengths and challenges of pharmacovigilance systems in Eswatini, Ethiopia, Nigeria and Tanzania, focusing on their capacity to monitor safety of medicines registered and not registered by the NMRAs for the treatment of DR-TB. Methods: Assessment visits were conducted to all four countries by a multidisciplinary team. We used a pharmacovigilance indicator tool derived from existing tools, interviewed key stakeholders, and visited health facilities where DR-TB patients were treated with new medicines. Assessment results were verified with the local NMRAs and NTPs.Results: Most countries have enabling laws, regulations and guidelines for the conduct of pharmacovigilance by the NMRAs. The relative success of NTP-NMRA collaboration iss much influenced by interpersonal relationships between staff. Division of roles and responsibilities is not always clear and leads to duplication and unfulfilled tasks (e.g. causality assessment). The introduction of aDSM has increased awareness and adverse drug reaction (ADR) reporting to the NMRAs among DR-TB healthcare providers.Conclusion: aDSM has created awareness about the importance of pharmacovigilance among NTPs and has increased ADR reporting rates from the NTPs and/or TB healthcare providers to the NMRAs. In the future, a push for conducting pharmacovigilance through public health programs seems useful, but this needs to coincide with increased collaboration with between public health programs and NMRAs with clear formulation of roles and responsibilities.


Author(s):  
Tessalyn Morrison ◽  
Alexis Dinno ◽  
Taurica Salmon

Abstract Sex and gender conflation continues to perpetuate the invisibility of sex and gender minorities and obscure information about the ways that biological sex and gender affect health. The misuse of sex and gender terms and the sex and gender binaries can yield inaccurate results, but more importantly, contributes to the erasure of intersex, transgender, nonbinary, and agender health experiences. This article discusses ways in which public health researchers can use sex and gender terms correctly, and center the health experiences of intersex, transgender, nonbinary, and agender individuals. This includes promoting sensitivity in approaching minority communities, improving survey questions, and collaborating with sex and gender minority communities to improve research quality and participant experiences. Improving our standards for the quality of sex and gender term usage and centering sex and gender minorities in public health research are imperative to addressing the health inequalities faced by sex and gender minorities.


Sign in / Sign up

Export Citation Format

Share Document